Introduction of Dietary Supplements to the Polish Market: Comprehensive Regulatory and Procedural Analysis

In this article you will read about:
    Add a heading to start generating the table of contents
    Scroll to Top

    INTERACTIVE GUIDE TO THE GIS DIETARY SUPPLEMENT NOTIFICATION PROCESS

    Registration of Dietary Supplements

    An interactive guide to the GIS notification process. Understand procedures, analyze key data, and learn about common challenges.

    Legal Basics and Definitions

    Before you begin the process, it's crucial to understand the basics. This section explains what a dietary supplement is, who regulates the market, and the legal framework.

    What is a Dietary Supplement?

    A food intended to supplement a normal diet. It is a concentrated source of vitamins, minerals, or other substances with a nutritional effect. It is not a medicine.

    The role of GIS

    The Chief Sanitary Inspectorate (GIS) is responsible for receiving and analyzing notifications of the first marketing of dietary supplements in Poland. GIS maintains a register and may initiate investigations.

    Legal Framework

    The process is regulated by both national law (Food and Nutrition Safety Act) and European Union regulations (e.g. on health claims and 'novel food').

    Interactive Notification Process

    The GIS supplement submission process consists of several key steps. Click on a step to see a detailed description and requirements.

    Step 1: Product Classification

    This is a fundamental first step. It's crucial to determine whether the product is a dietary supplement, a fortified food, or perhaps... a medicinal product.

    • Dietary supplement: Dietary supplement, concentrated source of ingredients.
    • Medicinal product: It has properties that prevent or treat disease. It requires a completely different path (registration with the Office for Registration of Medicinal Products).

    An error at this stage disqualifies the entire submission.

    Market in Numbers: Key Data

    Analyzing data from GIS reports allows us to understand the scale of the market, prevailing trends, and key risk areas. The following visualizations present selected statistics.

    Number of Notifications to GIS (Years)

    Number of Notifications to GIS (Years)
    Year Number of notifications
    2020 12000
    2021 14500
    2022 13800
    2023 16200
    2024 (Est.) 17500

    Main Supplement Categories (2024)

    Main Supplement Categories (2024)
    Category Percentage share
    Vitamins and minerals 45 %
    Herbal ingredients 25 %
    Probiotics 15 %
    Fatty acids 10 %
    Other 5%

    Most Common Reasons for Investigations

    Most Common Reasons for Investigations
    Cause Percentage of proceedings
    Inconsistent health claims 35 %
    Incorrect labeling (RDA, dosage) 30 %
    Suspected 'Novel Food' ingredient 20 %
    Doubts about the ingredient's safety 10 %
    Suggesting medicinal properties 5%

    Common Challenges and Pitfalls

    The notification process can be complex. Identifying potential issues early can save time and resources.

    ⚠️ Incorrect Labeling

    Labeling is one of the most frequently challenged elements. Errors include unauthorized health claims, claims of medicinal properties, or incorrect RDAs.

    ⚠️ 'Novel Food' Ingredients

    The use of an ingredient that has no history of consumption in the EU before 1997 (so-called novel food) requires special authorisation from the European Commission, and not just notification to the Chief Sanitary Inspectorate.

    ⚠️ Misclassification

    Classifying a product as a supplement when its composition (e.g. too high doses) or intended use indicate a medicinal product leads to immediate rejection.

    Post-Marketing Obligations

    Notification itself is just the beginning. The entrepreneur bears full responsibility for the safety and compliance of the product throughout its entire market lifecycle.

    • Full responsibility for the safety, composition and labeling of the product.
    • Monitoring changes in the law and adapting the product and labels to them.
    • Obligation to update reporting to GIS in the event of significant changes (e.g. change of composition, name, entity data).
    • Advertising supervision and marketing materials to comply with the regulations (prohibition of misleading, regulations regarding declarations).
    • Readiness to provide full documentation and research upon request of supervisory authorities (GIS, IJHARS).

    © 2025 Interactive GIS Guide. This website is for demonstration and information purposes only.

    The content is based on a hypothetical report and does not constitute legal advice.

     

    Section I: Legal Foundations and the Regulatory Landscape

    A. Introduction: Legal Paradox and Systemic Risk

    Introducing a dietary supplement to the Polish market poses a serious legal challenge. Legally, dietary supplements are simply foodstuffs intended to supplement a normal diet. [1] They are regulated by the Act of [25] August 2006 on Food and Nutrition Safety [2] , not the Pharmaceutical Law.

    This is completely at odds with how people perceive it. A report by the Supreme Audit Office ( NIK ) clearly states that, despite the law stating otherwise, supplements are perceived by many consumers as medicinal products. [3] NIK calls this a " threat to public health " because supplements, by definition, cannot have medicinal properties and cannot replace medications. [3]

    This difference between legal status (food) and public perception (medicine) makes authorities very suspicious. Regulators ( GIS , NIK ) are aware of this problem and strictly enforce the regulations.

    In this system, the most important thing is that the company that introduces the product to the market bears full responsibility . The company is responsible for the accuracy of the notification, and compliance of the composition, labeling, and marketing communications with regulations. [4]

    B. Key Regulatory Actors in Poland

    To navigate the Polish supplement market, you need to know the key institutions and regulations.


    📊 Key Legislation and Regulatory Bodies

    Body / Legal Act

    Role and Scope of Competence

    Key Provisions and References

    Chief Sanitary Inspector ( GIS )

    Main office. Receives notifications of first marketing. Maintains a product register. May initiate inspections.

    [3]

    State Sanitary Inspection ( PSSE / WSSE )

    Local offices (District and Voivodeship Sanitary and Epidemiological Stations, also known as Sanepid) are responsible for the registration and inspection of companies (production, storage, and distribution sites).

    [5]

    Dietary Supplements Team

    The GIS advisory team issues opinions on maximum doses and required warnings.

    [6]

    Food and Nutrition Safety Act

    The main Polish law on food, including dietary supplements (Section 7). It specifies the rules for product reporting (Articles 29-31) and explanatory proceedings.

    [2]

    Regulation of the Minister of Health on composition and labeling

    Polish regulation (consolidated text Journal of Laws 2023.79). Specifies detailed requirements for the composition (permitted vitamins and minerals) and required labeling of supplements.

    [14]

    Directive 2002/46/EC

    The EU's primary directive on food supplements. It establishes common lists of permitted vitamins and minerals.

    [16]

    Regulation (EC) No 1924/2006

    The EU Nutrition and Health Claims Regulation provides the basis for the EFSA register and prohibits claims that a product has healing properties.

    [18]


    C. "Soft Power": The Role and Impact of Resolutions of the Dietary Supplements Team

    The Dietary Supplements Team plays a special role in the Polish system. Formally, it is only a consultative and advisory body, and its resolutions "have no legal force." [10] However, ignoring these resolutions by entrepreneurs is a strategic mistake.

    In practice, these resolutions constitute de facto binding guidelines that are "used in practice by GIS " [10] during the evaluation of reported products and during explanatory proceedings. The team fills gaps in the law (especially in non-harmonized areas, such as herbal ingredients or maximum doses), creating market standards.

    Case Studies based on the Team's resolutions

    1. Vitamin D : In response to numerous notifications of products with high doses, GIS asked the Team for a position. [21] Based on the analysis of studies, the Team determined the maximum safe dose in dietary supplements for the healthy adult population to be [2] 000 IU (50 µg) per day. [21] Notification of a product with a higher dose (e.g. [4] 000 IU) without solid scientific justification almost guarantees the initiation of explanatory proceedings regarding qualification as a medicinal product.

    2. Caffeine: The Panel has established maximum levels and mandatory warnings that must appear on the label of products containing caffeine: "use in children and pregnant women is not recommended; do not consume with other products containing caffeine or other ingredients with a similar effect." [11]

    3. Plant extracts (white mulberry): The Panel's resolution precisely defined the maximum content of the active substance (1-deoxynojirimycin, DNJ) at [10] mg per daily dose. Furthermore, it imposed a mandatory warning: "in individuals using insulin therapy or oral hypoglycemic agents, use only after consulting a physician." [11]

    The strategy for minimizing regulatory risk must therefore assume treating the Team's resolutions as hard requirements at the stage of formulating the product recipe.

    Section II: Notification Procedure Step by Step

    A. Critical Distinction: "Notification" vs. "Registration"

    The term "registration of dietary supplements", although commonly used in everyday language (and in queries), is legally imprecise and fundamentally misleading.

    • Registration, as used for medicinal products, is a pre-market approval process. The regulatory authority (e.g., the Office for Registration of Medicinal Products) reviews the complete documentation and issues a marketing authorization.

    • Notification (notification), used for dietary supplements [7] , is the process of informing the authority ( GIS ) about the intention to introduce the product to the market.

    GIS does not issue a "permit." The product can be legally placed on the market (in principle) after the notification period (formerly [14] days) has passed, and the entire responsibility for its safety and legal compliance rests with the entrepreneur. [4]

    B. Step 1: Prerequisite – Registration of the Facility at the District Sanitary and Epidemiological Station (PSSE)

    Before an entrepreneur can register any product, they must first register their business (establishment). This applies to any entity that introduces supplements to the market, including manufacturers and importers. [9]

    The procedure involves submitting an application for entry into the "register of establishments subject to official control of the State Sanitary Inspection" to the appropriate District Sanitary and Epidemiological Station ( PSSE ). [9] This application must be submitted at least [14] days before the planned commencement of operations. [9]

    It is worth noting an important nuance regarding e-commerce: selling dietary supplements online does not require approval of the establishment (which involves a physical inspection of the facility), but it still requires reporting the business to the PSSE . [9]

    C. Step 2: Product Notification in the Electronic Notification System (ESP) GIS

    After registering the establishment, the entrepreneur is obliged to notify the Chief Sanitary Inspector ( GIS ) of each dietary supplement introduced to the market in Poland for the first time. [7]

    This process is carried out exclusively electronically via the Electronic Notification System (ESP), available on the e-Sanepid platform. [8]

    Technical and procedural requirements

    1. Account: The entity must set up an account in the e-Sanepid system. [8]

    2. Authentication: Submission requires the use of an electronic signature or a Trusted Profile. [25]

    3. Documentation: You must complete a detailed online form regarding the product (composition, dosage, etc.) [8] and attach a label template in Polish. [12]

    Risk Analysis (Practical Challenges): It should be noted that the new ESP system (implemented around February 2024) is causing significant difficulties. It is indicated that the system's functionality has changed significantly and currently "creates many practical challenges." [23] Businesses must allocate additional resources and time to address potential technical difficulties related to the notification system, which may unexpectedly delay the planned product launch.

    D. The Fee Issue: Legal Status and Regulatory Intentions

    In 2017, a draft amendment to the Act was widely discussed, which would introduce a fee of PLN 1000 for registering each dietary supplement. [26] The aim of this proposal was to limit the practice of "flood[ing] institutions with fictitious registrations." [26]

    However, analysis of available materials does not confirm the entry into force of this fee. [4] Currently (unless the regulations have changed and are not noted in the materials), product notification to the Chief Sanitary Inspectorate ( GIS) is free of charge. However, it should be remembered that the regulator's intention (to burden the market with costs in order to regulate it) is clear [26] , and costs may arise at the stage of any explanatory proceedings (e.g., costs of expert opinions).

    Section III: Post-Notification Risk Analysis: Explanatory Proceedings

    Submitting a notification does not end the regulatory process. It is, in fact, its beginning. The greatest risk for the entrepreneur is associated with the initiation of the so-called explanatory proceedings by the Chief Sanitary Inspectorate .

    A. The Essence and Reasons for Initiating the Proceedings

    The explanatory proceedings are, in fact, the only real mechanism for substantive control of products in the notification system, which is indirectly confirmed by the Supreme Audit Office report indicating that "the vast majority of supplements available on the market are not tested by anyone." [3]

    GIS is authorized (under Articles [30] and [31] of the Act on Food and Nutrition Safety) to initiate proceedings as soon as it "has doubts" regarding the notified product. [13]

    Main reasons for initiating the proceedings 13

    1. General doubts: Inconsistency of the name, composition or labelling declared in the ESP system with the actual state or legal requirements.

    2. Doubts about qualification: The most serious risk. GIS becomes suspicious that the reported product, due to its composition, dosage, presentation, or marketing communication, is in fact a medicinal product and not a dietary supplement. [13]

    B. Product Qualification: The Crucial "Gray Area"

    Responsibility for the correct classification of a product (food vs. drug) rests solely with the entrepreneur. [27] An error in this regard is the most serious regulatory violation. When assessing the classification, the Chief Sanitary Inspectorate (GIS) takes into account a number of product characteristics. [1]


    📊 Qualification Criteria: Dietary Supplement vs. Medicinal Product

    Criterion

    Dietary Supplement Characteristics (Low Risk)

    Summary of Product Characteristics (High Risk of Initiation of Proceedings)

    Composition and Dose

    Nutrients (vitamins, minerals), plant ingredients. [1] Doses intended to supplement the diet (e.g. Vitamin D ≤ [2] 000 IU 21).

    Substances with documented pharmacological activity. Doses producing a therapeutic, pharmacological effect (e.g. Vitamin D > [4] 000 IU).

    Purpose (Marketing)

    Purpose: Dietary supplement. Communication: "Supports", "Helps maintain". [28] Based on EFSA claims . [29]

    Goal: Treatment, prevention of disease. Communication: "Treats," "Prevents," "Natural remedy for." [28]

    The presentation

    Typical food form (e.g. jar, bag, capsules in a bottle).

    A form suggesting a medical effect (e.g., ampoules for injection, blisters with a dosage like a drug). [1]

    Risk of Use

    Food-specific risks, such as hypersensitivity or overconsumption.

    Risks requiring medical supervision; interactions with drugs (e.g. as in the case of white mulberry and hypoglycemic drugs 11).


    C. Course and Legal Consequences of the Proceedings

    During the proceedings, the Chief Sanitary Inspectorate (GIS) requests the entrepreneur to submit additional documentation, scientific opinions, or expert opinions (e.g., from the Office for Registration of Medicinal Products or scientific units) in order to defend the product's qualification. [13] The entrepreneur bears the costs of these expert opinions.

    Procedural Problem (Legal Trap): The key problem is the form in which such proceedings are concluded. In the case of a negative assessment, the Chief Sanitary Inspectorate (GIS) often informs the entrepreneur of its findings (e.g., "the product does not qualify as a dietary supplement") in the form of a standard letter, which is not an administrative decision or resolution. [27]

    This approach by the Chief Sanitary Inspectorate (GIS) is a procedural trap. According to the Code of Administrative Procedure, the letter cannot be appealed (to a higher authority) or filed a complaint. [27] The entrepreneur is left with a negative opinion that de facto blocks their market access, with no clear appeal path.

    Legal Strategy: Case law analysis [27] points to groundbreaking decisions of the Supreme Administrative Court (NSA). The NSA found that such a letter from the Chief Administrative Court , informing about the outcome of the proceedings, falls within the category of "acts or activities" within the scope of public administration, which are subject to appeal to the Provincial Administrative Court (WSA) under Article [3] § [2] of the Law on Administrative Court Procedure (PPSA). [27] This is the only, albeit non-standard and costly, path of defense against a negative classification of the Chief Administrative Court.

    Section IV: Product Compliance Requirements: Marking (Labelling)

    The marking (label) is one of the key elements subject to inspection. It is also a mandatory attachment for notification in the ESP system. [12]

    A. Legal Basis for Labeling

    The labeling of dietary supplements in Poland is subject to a dual legal regime.

    1. General EU legislation: Regulation (EU) No 1169/2011 of the European Parliament and of the Council on the provision of food information to consumers. [14]

    2. Detailed national regulations: Regulation of the Minister of Health on the composition and labeling of dietary supplements (consolidated text Journal of Laws 2023.79). [14]

    All mandatory information must be presented in Polish. [12]

    B. Mandatory Label Elements in Polish

    The table below presents the key mandatory elements that must be included on the label of every dietary supplement introduced to the Polish market.


    📊 Mandatory Elements of Dietary Supplement Labeling in Poland (Compliance Checklist)

    Category

    Mandatory Element/Wording

    Source / Reference

    Product Identification

    Term: "Dietary supplement".

    [14]

    Composition

    Names of categories of nutrients or substances that characterize the product.

    [14]

    Declaration of Content

    The content of vitamins, minerals and other substances with a nutritional/physiological effect, declared in numerical form and in relation to the recommended daily dose.

    [14]

    How to Use

    Recommended daily intake.

    [31]

    General Warning 1

    Statement: "Do not exceed the recommended daily dose."

    [31]

    General Warning 2

    Statement: "A dietary supplement cannot be used as a substitute for a varied diet."

    [32]

    General Warning 3

    Statement: "Keep out of reach of small children."

    [14]

    Special Warnings

    Any additional warnings resulting from the product composition, in particular those recommended in the Resolutions of the Dietary Supplements Committee (e.g. regarding caffeine, white mulberry, pregnancy).

    [11]


    Section V: Market Compliance Requirements: Advertising and Health Claims

    Marketing communication and advertising of dietary supplements are an area as rigorously controlled as composition and labeling, and the potential financial penalties here are sometimes the highest.

    A. Legal basis: Regulation (EC) No 1924/2006

    The key piece of legislation here is Regulation (EC) No. 1924/2006 on nutrition and health claims made on foods. [18] It aims to protect consumers from false, ambiguous, or misleading information. [18]

    This regulation, as well as Polish law, establishes categorical prohibitions 18

    1. Prohibition of Medicinal Claims: Food claims (including supplements) must not claim to prevent or treat human diseases. [28] Phrases such as "Cures colds" or "Prevents disease" are strictly prohibited. [28]

    2. Dietary undermining prohibited: Claims must not imply that a balanced and varied diet cannot provide adequate amounts of nutrients. [18]

    3. No raising doubts: Claims must not raise doubts about the safety or nutritional adequacy of other foods. [18]

    B. Register EFSA: The Single Source of Permitted Claims

    Every health claim (e.g., "Vitamin C contributes to the normal function of the immune system") must be compliant with the European Union Register of Nutrition and Health Claims. [29] This Register, maintained by the European Commission based on scientific opinions from EFSA (European Food Safety Authority), includes:

      1. Authorized statements
    • Non-authorized claims: Prohibited for use. The most common reason for rejection is "no demonstrated cause-and-effect relationship" between the ingredient and the claimed effect. [20]


    📊 Permitted and Prohibited Formulations in Dietary Supplement Advertising

    ✅ ALLOWED (Based on EFSA claims /general function support)

    ❌ PROHIBITED (Suggesting medicinal properties / misleading)

    "Supports immunity" (with vitamin C)

    "Cures colds"

    “Helps maintain healthy bones” (with calcium)

    "Treats osteoporosis"

    "Iron Dietary Supplement"

    "Natural cure for anemia"

    "Contains vitamin D"

    "Prevents disease"

    Source: Based on 28


    C. Strategy and Risk of On-Hold (Pending) Statements

    A special category is "botanical" claims (regarding plant ingredients). Thousands of such claims are pending EFSA evaluation (they are "on-hold"). [37] This has created a regulatory "gray area."

    Market analysis indicates that businesses treat "on hold" status as a temporary license to use traditional claims. [38] For example, a product containing Nigella sativa (black cumin), which is on the "on hold" list, is described as "traditionally supporting immunity." [38] This is a high-risk strategy. By the time EFSA finally assesses these claims (and many are rejected20), entire product lines based on this marketing will require immediate rebranding or be withdrawn from the market.

    D. The Role of Doctors and Advertising Penalties

    The law generally allows the use of a doctor's or expert's image in online dietary supplement advertising. [28] However, there is a key restriction: such a recommendation cannot imply the medicinal nature of the supplement or be misleading. [28]

    Advertising violations are subject to very high penalties. The draft amendment to the Food and Nutrition Safety Act envisaged fines of up to PLN 20 million for failure to comply with the planned advertising restrictions. [26]

    Section VI: Import Scenarios: Introduction of Products from Abroad

    The procedure for introducing a supplement to the Polish market varies dramatically depending on the product's country of origin.

    A. Imports from the Territory of the European Union (Internal Market)

    There is a common misconception among importers that a product legally sold in another EU country (e.g. Germany) can automatically be sold in Poland without any restrictions under the principle of mutual recognition (Regulation 764/2008). [16]

    This is not true. The principle of mutual recognition has very limited application in the case of dietary supplements, as it does not cover aspects already harmonized at EU level. [16]

    The harmonized aspects (and not subject to mutual recognition) are 16

    1. Composition (Vitamins and Minerals): The lists of permitted vitamins, minerals and their chemical forms are harmonized by Directive 2002/46/EC. [16]

    2. Labelling: Labelling rules are harmonised by Regulation 1169/2011 and Articles 6-9 of Directive 2002/46/EC. [16]

    3. Health Claims: The conditions for the use of claims are fully harmonized by Regulation 1924/2006. [16]

    In practice, the principle of mutual recognition applies almost exclusively to non-harmonized ingredients (mainly plant-based). Every EU product must be notified in the Polish GIS system [7] , must have a label in Polish [12] , and is subject to the full jurisdiction of the GIS , including the risk of initiating an investigation. [13]

    B. Imports from Third Countries (Non-EU)

    Importing dietary supplements from outside the European Union is a much more complex process and carries greater entry barriers. [39] It is a two-stage procedure.

    Stage 1: Border Sanitary Control

    The entrepreneur (importer) must submit the goods for inspection to the State Border Sanitary Inspector. [40] This inspection includes verification of documentation (e.g., health certificates from the country of origin) and, if necessary, physical inspection and laboratory testing of samples.

    • Positive result: The authority issues a "certificate" confirming compliance with EU health requirements, which allows the goods to be released for circulation within the EU (after customs clearance). [40]

    • Negative result: The authority issues a "decision prohibiting the introduction of goods into circulation." [40] This procedure can be handled via electronic platforms, e.g. PUESC. [41]

    Stage 2: National Notification ( GIS )

    Successful completion of border control and customs clearance does not release the importer from domestic obligations. After the goods enter Poland, the importer must still submit a standard product notification to the Chief Sanitary Inspectorate (GIS) via the ESP system [8] , in accordance with the procedure described in Section II.

    Section VII: Liability and Sanctions for Non-Compliance

    The notification system is based on the full and undivided responsibility of the entrepreneur. The consequences of violating the regulations are severe and multi-level.

    A. Absolute Responsibility of the Entity

    Full responsibility for the product's compliance with the law (composition, labeling, advertising) rests with the manufacturer.iocthe one who introduces it to the market, i.e. the one who formally submits the notification.[4]

    It should be emphasized that in the event of an audit, "it does not matter who physically submitted the documents" (e.g., an external consulting or law firm) – the legal and financial responsibility rests with the entity formally responsible for the product. [4]

    B. Catalog of Administrative and Criminal Penalties

    In the event of a violation of the regulations, GIS has a wide range of sanctions at its disposal:

    1. Administrative Sanctions (Immediate Response):

    • Issuing an administrative decision to suspend trade in a given product.

    • Issuing a decision to withdraw a product from the market (recall).

    1. Financial Sanctions:

    • Imposing a financial penalty (fine) which may amount to "up to [50] thousand PLN". [4]

    • Potentially much higher fines (up to PLN [20] million, as indicated in draft 26) may be imposed for unlawful advertising.

    1. Criminal Sanctions (Highest Risk):

    • If the Chief Sanitary Inspectorate determines that a supplement (e.g., due to contamination or misleading information about its composition) "poses a threat to health or life," the case is referred to law enforcement agencies (the prosecutor's office). [4]

    1. Reputational Sanctions:

    • The risk of publishing information about the decision or a public warning on the GIS website or in the media. [4] Such information could permanently damage consumer trust in the brand and the company's entire product portfolio.

    Section VIII: Recommendations and Risk Minimization Strategies

    A. Conclusion: High Risk Market Requires Proactivity

    An analysis of the regulatory framework leads to the conclusion that the Polish dietary supplement notification system is deceptive. The apparent ease of the procedure (online notification via the ESP system) conceals a complex regulatory ecosystem. This system is characterized by:

    • A significant impact of de facto regulations ("soft law" in the form of Resolutions of the Team for Dietary Supplements).

    • Opaque and risky legal procedures (status of the GIS letter concluding the explanatory proceedings).

    • Severe sanctions (financial, administrative and even criminal) for incorrect product classification or misleading.

    A reactive approach ("we'll report it and see what happens") is a high-risk strategy. Success in this market requires proactive compliance management at every stage of the product lifecycle.

    B. Strategic Checklist (Due Diligence) Before Notification

    In order to minimize regulatory, financial and reputational risk, an entity intending to introduce a dietary supplement to the market should conduct a rigorous internal audit before submitting a notification in the ESP system:

    1. Formulation Audit:

    • The quantitative and qualitative composition of the product must be verified for compliance with the Resolutions of the Dietary Supplements Committee. [10]

    • Action: Check ingredient dosages (e.g., whether Vitamin D does not exceed [2] 000 IU [21] , whether caffeine is within the 11 limits) and whether the formula does not contain ingredients questioned by the Panel. Any discrepancies must be eliminated or supported by very strong, individual scientific documentation.

    1. Qualification Audit:

    • An internal product qualification risk assessment should be performed using the criteria in Table [3] (based on 1).

    • Action: Assess whether the dosage, presentation (e.g., ampoules), communication, or risk of use bring the product dangerously close to the definition of a medicinal product. If in doubt, consider changing the formulation or presentation.

    1. Label Audit:

    • The label design should be verified against the checklist of mandatory elements (Table [2] , based on 14).

    • Action: Ensure that all legally required statements and warnings (“Do not exceed…”, “This dietary supplement should not be used as a substitute for…”, “Keep out of reach of small children”) are present, visible, and in Polish. [12]

    1. Marketing & Claims Audit:

    • All planned advertising materials, descriptions on websites and social media should be checked for compliance with Regulation 1924/2006. [18]

    • Action: Verify each health claim against the EFSA Register . [29] Strictly eliminate all medicinal claims ("treats", "prevents", "cure for..."). [28]

    1. Legal Readiness:

    • A legal strategy should be developed in the event of receiving a negative letter from the Chief Sanitary Inspectorate following any investigation.

    • Action: Ensure preparedness (budgetary and substantive) to appeal such a letter to the Provincial Administrative Court (WSA) based on the Supreme Administrative Court's case law. [27]

    Cited works and legal sources

    1. Drug and dietary supplement differences, how to define the difference | Recepty24 https://recepty24.com/lek-a-suplement-diety-na-czym-polega-roznica/
    2. Act on Food and Nutrition Safety (Journal of Laws 2006, No. 171, item 1225) https://lexlege.pl/ustawa-o-bezpieczenstwie-zywnosci-i-zywienia/art-27/
    3. LICENSE OF DIETARY SUPPLEMENTS FOR MARKETING – NIK Report https://www.nik.gov.pl/plik/id,13031,vp,15443.pdf
    4. How to legally report a dietary supplement to the Chief Sanitary Inspectorate (GIS)? – RPMS Law Firm https://rpms.pl/jak-zgodnie-z-prawem-zglosic-suplement-diety-do-gis/
    5. Dietary supplements – Provincial Sanitary and Epidemiological Station in Warsaw https://www.gov.pl/web/wsse-warszawa/obzzik-suplementy-diety
    6. Dietary Supplements Team – Chief Sanitary Inspectorate https://www.gov.pl/web/gis/zespol-do-spraw-suplementow-diety
    7. Registration of dietary supplements. Introduction to the Polish market. https://produkcjanazlecenie.pl/wprowadzenie-do-obrotu-suplementow-diety/
    8. Electronic Notification System (ESP) – e-Sanepid https://e.sanepid.gov.pl/e-services/BZ_POZWPWO
    9. Dietary Supplement Registration: A Complete Guide to the Process https://www.skutecznyebiznes.pl/blog/rejestracja-suplementu-diety-kompletny-przewodnik-po-procesie-i-wymaganiach
    10. Sensitive products in a nutshell – resolutions of the Dietary Supplements Team https://ajlaw.pl/produkty-sensytywne-w-pigulce-w-praktyce/
    11. GIS has determined the maximum content of ingredients in supplements http://www.chpl.com.pl/gis-okreslil-maksymalna-zawartosc-siedmiu-skladnikow-w-suplementach-diety,2841,artykul.html
    12. Notification of the first introduction of a product to the market – Biznes.gov https://www.biznes.gov.pl/pl/portal/ou465
    13. What is the registration investigation procedure? – Zboralska Law Firm https://zboralska-kancelaria.pl/co-to-jest-postepowanie-wyjasniajace-podczas-rejestracji-notyfikacji-suplementu-diety/
    14. Regulation of the Minister of Health on the composition and labeling of dietary supplements (Journal of Laws 2023.79) https://sip.lex.pl/akty-prawne/dzu-dziennik-ustaw/sklad-oraz-oznakowanie-suplementow-diety-17385919
    15. Directive 2002/46/EC (Food Supplements) – EUR-Lex https://eur-lex.europa.eu/PL/legal-content/summary/ensuring-safe-food-supplements-in-the-eu.html
    16. Regulation 1924/2006 on nutrition and health claims https://sip.lex.pl/akty-prawne/dzienniki-UE/rozporzadzenie-1924-2006-w-sprawie-oswiadczen-zywieniowych-i-zdrowotnych-67656301
    17. Special properties of food – claims about reducing the risk of disease https://ncez.pzh.gov.pl/dla-producentow-zywnosci/szczegolne-wlasciwosci-zywnosci-oswiadczenia-o-zmniejszaniu-ryzyka-choroby/
    18. What is a safe dose of vitamin D in dietary supplements? – Termedia https://www.termedia.pl/mz/Jaka-jest-bezpieczna-dawka-witaminy-D-w-suplementach-diety-,34590.html
    19. New GIS notification system – Food Law Center https://food-law.pl/nowy-system-notyfikacji-gis/
    20. Fees for reporting supplements to GIS – Merchant's Guide https://poradnikhandlowca.com.pl/artykuly/oplaty-za-zglaszanie-suplementow-do-gis/
    21. Can the result of the explanatory proceedings before the Chief Sanitary Inspectorate be questioned? https://food-law.pl/czy-wynik-postepowania-wyjasniajacego-przed-gis-mozna-kwestionowac/
    22. How to Advertise Dietary Supplements? Advertising Rules – Creativa Legal https://creativa.legal/jak-reklamowac-suplementy-zasady-i-zmiany-dotyczace-reklamy-suplementow-diety/
    23. EU Register of Health Claims – European Commission https://food.ec.europa.eu/food-safety/labelling-and-nutrition/nutrition-and-health-claims/eu-register-health-claims_en
    24. Health claims (Article 13) – EFSA https://www.efsa.europa.eu/en/topics/health-claims-art-13
    25. Import from outside the EU: How to legally introduce products to the Polish market? https://adwokat-mc.pl/import/
    26. Report goods to border sanitary inspection – Biznes.gov https://www.biznes.gov.pl/pl/portal/ou1522
    27. Obtain border sanitary documents – PUESC https://puesc.gov.pl/uslugi/uzyskaj-graniczne-dokumenty-sanitarne
     
    Scroll up